- Home » News and Events
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
May 8, 2024
Experts and speakers from Catalent and JLABS will be joined by speakers from Johnson & Johnson and Cardiff Advisory LLC.
Catalent Publishes Fifth Annual Corporate Responsibility Report
Mar 7, 2024
The 2023 Corporate Responsibility Report highlights progress across every pillar of Catalent’s corporate responsibility strategy – People, Environment, and Community.
Novo Holdings to Acquire Catalent
Feb 5, 2024
Catalent and Novo Holdings have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.
Catalent Announces Addition of Potent Capsule Filling Capabilities for Inhaled Dry Powders at its Boston, MA USA Facility
Feb 2, 2024
These upgrades, including the addition of capacity for both development and commercial spray drying, now position Catalent as the CDMO with the largest GMP capacity for capsule spray-dried and carrier-based inhaled powders.
Catalent Commits to Reducing Greenhouse Gas Emissions by 2030
Jan 25, 2024
The company also committed to engaging with its suppliers such that 70% of their emissions will have reduction goals aligned with science-based targets by the end of fiscal 2028.
Catalent Appoints David McErlane as Biologics Segment Leader
Sep 18, 2023
Mr. McErlane will lead all of Catalent’s Biologics businesses and global service offerings – including development, drug substance manufacturing, drug product fill-and-finish, cell and gene therapy, and analytical services.
Catalent Appoints Lisa Evoli Senior Vice President and Chief Human Resources Officer
Aug 1, 2023
She will be responsible for leading Catalent’s global human resources strategy, including talent acquisition, leadership development, diversity and inclusion, compensation and benefits, HR operations and technology, and performance management.
Catalent Appoints Matti Masanovich Senior Vice President & Chief Financial Officer
Jun 20, 2023
Mr. Masanovich will have responsibility for all aspects of Catalent’s global financial operations, including financial planning and analysis, controllership, public reporting and investor relations, capital markets activities, bill payment and collection, tax, and treasury.
Catalent and JLABS Symposium to Discuss Accelerated Development and Manufacturing of Biologics
Jun 7, 2023
Experts and speakers from Catalent and JLABS will be joined by speakers from Johnson & Johnson and Cardiff Advisory LLC.
ASGCT
Date: May 7-11, 2024
AAPS National Biotechnology Conference
Date: May 13-16, 2024
Vitafoods Europe
Date: May 14-16, 2024
Knowledge for Growth
Date: May 15-16, 2024
ATS 2024 Respiratory Innovation Summit
Date: May 17-22, 2024
2024 DIA China
Date: May 17-19, 2024
Enabling Adaptive Clinical Trials through Integrated Development and Manufacturing Solutions
Date: May 21, 2024
ALS Drug Development Summit 2024
Date: May 21-23, 2024
DDF Summit EU
Date: May 21-23, 2024
Extractables and Leachables USA 2024
Date: May 21-22, 2024
ISCT 2024 Annual Meeting
Date: May 29 – June 1, 2024
Bio International
Date: June 3-6, 2024